CYRO Industries

Medical device manufacturers can now improve drug delivery efficiency with CYRO Industries’ new Vu-Stat® Y-20 static dissipative acrylic multipolymer compound. Developed for injection molding applications, Vu-Stat Y-20 compound provides permanent electro-static dissipative (ESD) protection to medical devices where static attraction is a concern, such as needle hubs for bracheotherapy and spacers for dry powder pharmaceutical inhalation. With excellent durability and optical clarity, this advanced acrylic compound offers superior balance of mechanical, thermal and flow properties.Static charge may weaken the performance of drug delivery devices by impeding passage of drug particles. To combat this tendency, Vu-Stat Y-20 compound incorporates advanced static dissipative technology directly into its formulation. Unlike compounds that rely on topical ESD coatings, Vu-Stat Y-20 compound offers static protection that cannot be compromised by surface scratches or abrasions. Vu-Stat Y-20 compound is also not dependent upon moisture or humidity for its effectiveness and retains its superior ESD properties even after repeated washing cycles.“With its durability, optical transparency, and unparalleled ability to consistently deliver static-free results, versatile Vu-Stat Y-20 compound is ideal for medical device design,” explains Pete Colburn, Technical Manager, Polymers at CYRO Industries.Available in pellet form, Vu-Stat Y-20 compound can be sterilized via EtO, e-beam or gamma radiation with no effect on appearance and processed in all types of injection molding presses.